Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain

Journal of Neural Transmission

Volumn 119, Issue 4, 2012, Pages 481-491

  Réus, Gislaine Z ^a   Stringari, Roberto B ^a   Rezin, Gislaine T ^a   Fraga, Daiane B ^a   Daufenbach, Juliana F ^a   Scaini, Giselli ^a   Benedet, Joana ^a   Rochi, Natália ^a   Streck, Emílio L ^a   Quevedo, João ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Creatine kinase; Imipramine; Memantine; Mitochondrial respiratory chain; NMDA receptor

Indexed keywords

CREATINE KINASE; IMIPRAMINE; MEMANTINE; MULTIENZYME COMPLEX;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; TREATMENT DURATION;

ADRENERGIC UPTAKE INHIBITORS; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CREATINE KINASE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIPRAMINE; MALE; MEMANTINE; MULTIENZYME COMPLEXES; NADH DEHYDROGENASE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84862277367     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0718-2     Document Type: Article

References (91)

1. Almeida A, Heales SJR, Bolanos JP, Medina JM (1998) Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res 790:209-216. doi:10.1016/S0006-8993(98) 00064-X
2. Almeida RC, Felisbino CS, López MG, Rodrigues ALS, Gabilan NH (2006) Evidence for the involvement of L-arginine-nitric oxidecyclic guanosine monophosphate pathway in the antidepressantlike effect of memantine in mice. Behav Brain Res 168:318-322. doi:10.1016/j.bbr.2005.11.023
3. Arundine M, Tymianski M (2003) Molecular mechanisms of calciumdependent neurodegeneration in excitotoxicity. Cell Calcium 34:325-337. doi:10.1016/S0143-4160(03)00141-6
4. Assis LC, Rezin GT, Comim CM, Valvassori SS, Jeremias IC, Zugno AI, Quevedo J, Streck EL (2009) Effect of acute administration of ketamine and imipramine on Creatine kinase activity in the brain of rats. Rev Bras Psiquiatr 31:247-252. doi:10.1590/S1516-44462009000300010
5. Ben-Shachar D, Karry R (2008) Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One 3:3676. doi: 10.1371/journal.pone.0003676
6. Beretta S, Wood JP, Derham B, Sala G, Tremolizzo L, Ferrarese C, Osborne NN (2006) Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON). Neurobiol Dis 24:308-317
7. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351-354. doi: 10.1016/S0006-3223(99)00230-9
8. Bessman SP, Carpenter LC (1985) The creatine-creatine phosphate energy shuttle. Annu Rev Biochem 54:831-865. doi:10.1146/annurev.bi.54.070185.004151
9. Bindoff LA, Birch-Machin M, Cartlidge NE, Parker WD, Turnbull DM (1989) Mitochondrial function in Parkinson's disease. Lancet 2:49
10. Brookes PS, Land JM, Clark JB, Heales SJ (1998) Peroxynitrite and brain mitochondria: evidence for increased proton leak. J Neurochem 70:2195-2202
11. Calabrese V, Scapagnini G, Giuffrida-Stella AM, Bates TE, Clark JB (2001) Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem Res 26:739-764. doi:10.1023/A:1010955807739
12. Cassina A, Radi R (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328:309-316. doi:10.1006/abbi.1996.0178
13. Chang DT, Honick AS, Reynolds IJ (2006) Mitochondrial trafficking to synapses in cultured primary cortical neurons. J Neurosci 26:7035-7045
14. Chinnery PF, Schon EA (2003) Mitochondria. J Neurol Neurosurg Psychiatry 74:1188-1199. doi:10.1136/jnnp.74.9.1188
15. Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C, Hortnagl H, Riva MA, Sprengel R, Gass P (2008) AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEP J. 22:3129-3134. doi: 10.1096/fj.08-106450
16. Corrêa C, Amboni G, Assis LC, Martins MR, Kapczinski F, Streck EL, Quevedo J (2007) Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 31:887-891. doi:10.1016/j.pnpbp.2007.02.005
17. Covington HE, Vialou V, Nestler EJ (2010) From synapse to nucleus: novel targets for treating depression. Neuropharmacology 58:683-693. doi:10.1016/j.neuropharm.2009.12.004
18. Crane GE (1959) Cycloserine as an antidepressant agent. Am J Psychiatry 115:1025-1026
19. Curti C, Mingatto FE, Polizello AC, Galastri LO, Uyemura SA, Santos AC (1999) Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity. Mol Cell Biochem 199:103-109. doi:10.1023/A:1006912010550
20. Duchen MR (2004) Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med 25:365-451. doi:10.1016/j.mam.2004. 03.001
21. Ferguson JM, Shingleton RN (2007) An open-label, flexible-dose study of memantine in major depressive disorder. Clin Neuropharmacol 30:136-144. doi:10.1097/WNF.0b013e3180314ae7
22. Feyissa AM, Chandran A, Stockmeier CA, Karolwecz B (2009) Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry 33:70-75. doi:10.1016/j.pnpbp.2008.10.005
23. Fisar Z, Hroudova J (2010) Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinol Lett 31:123-153
24. Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, Sengers RC, Janssen AJ (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 153:23-26
25. Garcia LB, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries G, Gavioli E, Kapczinski F, Quevedo J (2008a) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32:140-144. doi:10.1016/j.pnpbp.2007.07.027
26. Garcia LB, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries G, Gavioli E, Kapczinski F, Quevedo J (2008b) Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol 103:502-506. doi:10.1111/j.1742-7843.2008.00210.x
27. Garcia LS, Comim CM, Valvassori SS, Réus GZ, Stertz L, Kapczinski F, Gavioli EC, Quevedo J (2009) Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 33:450-455. doi:10.1016/j.pnpbp.2009.01.004
28. Garthwaite J, Charles SL, Chess-Williams R (1988) Endotheliumderived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-388
29. Gingrich JR, Pelkey KA, Fam SR, Huang Y, Petralia RS, Wenthold RJ, Salter MV (2004) Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2. Proc Natl Acad Sci USA 101:6237-6241. doi:10.1073/pnas.0401413101
30. Hall J, Whalley HC, Marwick K, Mckirdy J, Sussmann J, Romaniuk L, Johnstone EC, Wan HI, Mclntosh AM, Lawrie SM (2009) Hippocampal function in schizophrenia and bipolar disorder. Psychol Med 7:1-10
31. Hardingham GE, Bading H (2003) The Yin and Yang of NMDA receptor signalling. Trends Neurosci 26:81-89. doi:10.1016/S0166-2236(02)00040-1
32. Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62:1310-1316. doi:10.1016/j.biopsych.2007.03.017
33. Hassel S, Almeida JR, Kerr N, Naus S, Ladouceur CD, Fissell K, Kupfer DJ, Phillips ML (2008) Elevated striatal and decreased dorsolateral prefrontal cortical activity in response to emotional stimuli in euthymic bipolar disorder: no associations with psychotropic medication load. Bipolar Disord 10:916-927
34. Heinemann U, Buchheim K, Gabriel S (2002) Cell death and metabolic activity during epileptiform discharges and status epilepticus in the hippocampus. Prog Brain Res 135:197-210
35. Horn D, Barrientos A (2008) Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB Life 60:421-429. doi: 10.1002/iub.50
36. Hughes BP (1962) A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clin Chim Acta 7:597-604
37. Jou SH, Chiu NY, Liu CS (2009) Mitochondrial dysfunction and psychiatric disorders. Chang Gung Med J 32:370-379
38. Karanian DA, Baude AS, Brown QB, Parsons CG, Bahr BA (2006) 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. Hippocampus 16:834-842
39. Kato T, Kato N (2000) Mitochondrial dysfunction in bipolar disorder. BipolarDisord 2:180-190. doi:10.1034/j.1399-5618.2000.020305.x
40. Khuchua ZA, Qin W, Boero J, Cheng J, Payne RM, Saks VA, Strauss AW (1998) Octamer formation and coupling of cardiac sarcomeric mitochondrial Creatine kinase are mediated by charged N-terminal residues. J Biol Chem 273:22990-22996. doi: 10.1074/jbc.273.36.22990
41. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300-308
42. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894-992. doi:10.1038/nature07455
43. Kudin AP, Malinska D, Kunz WS (2008) Sites of generation of reactive oxygen species in homogenates of brain tissue determined with the use of respiratory substrates and inhibitors. Biochim Biophys Acta 1777:689-695
44. Lee TY, Tsai KL, Lee WS, Hsu C (2007) The molecular events occur during MK-801-induced cytochrome oxidase subunit II downregulation in GT1-7 cells. J Mol Endocrinol 39:53-66. doi: 10.1677/jme.1.00002
45. Liebrenz M, Borgeat A, Leisinger R, Stohler R (2007) Intravenous ketamine therapy in a patient with a treatment-resistant major depression. Swiss Med Wkly 137:234-236
46. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632
47. Lowry OH, Rosebough NG, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
48. Lucca G, Comim CM, Valvossori SS, Réus GZ, Vuolo F, Petronilho F, Gavioli EC, Dal-Pizzol F, Quevedo J (2009) Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J Psychiatr Res 43:864-869. doi:10.1016/j.jpsychires.2008.11. 002
49. Madrigal JLM, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J, Leza JC (2001) Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 24:420-429. doi: 10.1038/sj.npp.1395616
50. Malinska D, Kulawiak B, Kudin AP, Kovacs R, Huchzermeyer C, Kann O, Szewczyk A, Kunz WS (2010) Complex III-dependent superoxide production of brain mitochondria contributes to seizure-related ROS formation. Biochim Biophys Acta 1797:1163-1170
51. Mathers C, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:442. doi: 10.1371/journal.pmed.0030442
52. McAllister J, Ghosh S, Berry D, Park M, Sadeghi S, Wang KX, Parker WD, Swerdlow RH (2008) Effects of memantine on mitochondrial function. Biochem Pharmacol 75:956-964. doi: 10.1016/j.bcp.2007.10.019
53. Meltzer HY (2000) Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message? Psychopharmacology 150:349-350. doi:10.1007/s002130000465
54. Muhonen LH, Lönnqvist J, Lahti J, Alho H (2009) Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence. Psychiatr Res 167:115-122. doi:10.1016/j.psychres.2008.05.001
55. Nicholls DG (2004) Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med 4:149-177
56. Nicholls DG, Ward MW (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci 23:166-174
57. Nicholls DG, Vesce S, Kirk L, Chalmers S (2003) Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 34:407-424
58. Oliet SH, Piet R, Poulain DA (2001) Control of glutamate clearance and synaptic efficacy by glial coverage of neurons. Science 292:923-926
59. Parker WD, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26:719-723
60. Patel MN (2002) Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Radic Res 36:1139-1146
61. Paxinos G, Watson C (1986) The rat brain: stereotaxic coordinates, Second edn. Academic Press, Australia
62. Phelps LE, Brutsche N, Moral JR, Luckenbaugh DA, Manji HK, Zarate CA Jr (2009) Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry 65:181-184. doi:10.1016/j.biopsych.2008.09.029
63. Pietá Dias C, Martins De Lima MN, Presti-Torres J, Dornelles A, Garcia VA, Siciliani Scalco F, Rewsaat Guimarães M, Constantino L, Budni P, Dal-Pizzol F, Schröder N (2007) Memantine reduces oxidative damage and enhances long-term recognition memory in aged rats. Neuroscience 146:1719-1725
64. Réus GZ, Stringari RB, Kirsch TR, Fries GR, Kapczinski F, Roesler R, Quevedo J (2010) Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Brain Res Bull 81:585-589. doi: 10.1016/j.brainresbull.2009.11.013
65. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL (2009a) Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34:1021-1029. doi:10.1007/s11064-008-9865-8
66. Rezin GT, Gonçalves CL, Daufenbach JF, Fraga DB, Santos PM, Ferreira GK, Hermani FV, Comim CM, Quevedo J, Streck EL (2009b) Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress. Brain Res Bull 79:418-421. doi:10.1016/j.brainresbull.2009.03.010
67. Rogóz Z, Skuza G, Maj J, Danysz W (2002) Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacololgy 42:1024-1030. doi:10.1016/S0028- 3908(02)00055-2
68. Rogóz Z, Skuza G, Legutko B (2008) Repeated co-treatment with fluoxetine and amantadine induces brain-derived neurotrophic factor gene expression in rats. Pharmacol Rep 60:817-826
69. Rojas JC, Saavedra JA, Gonzalez-Lima F (2008) Neuroprotective effects of memantine in a mouse model of retinal degeneration induced by rotenone. Brain Res 1215:208-217
70. Rosenstock TR, Carvalho AC, Jurkiewicz A, Frussa-Filho R, Smaili SS (2004) Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J Neurochem 88:1220-1228
71. Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray JM, Munnich A (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228:35-51
72. Santos PM, Scaini G, Rezin GT, Benedet J, Rochi N, Jeremias GC, Carvalho-Silva M, Quevedo J, Streck EL (2009) Brain creatine kinase activity is increased by chronic administration of paroxetine. Brain Res Bull 80:327-330. doi:10.1016/j.brainresbull.2009.09.007
73. Schlattner U, Wallimann T (2000) Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding. J Biol Chem 275:17314-17320. doi:10.1074/jbc.M001919200
74. Schulz JB, Matthews RT, Henshaw DR, Beal MF (1996) Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neuroscience 71:1043-1048
75. Segal M, Avital A, Drobot M, Lukanin A, Derevenski A, Sandbank S, Weizman A (2007a) CK levels in unmedicated bipolar patients. Eur Neuropsychopharmacol 17:763-767. doi:10.1016/j.euroneuro.2007.04.007
76. Segal M, Avital A, Drobot M, Lukanin A, Derevenski A, Sandbank S, Weizman A (2007b) Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients. Eur. Neuropsychipharmacol. 17:194-198. doi:10.1016/j.euroneuro.2007.04.007
77. Shin JB, Streijger F, Beynon A, Peters T, Gadzala L, McMillen D, Bystrom C, Van der Zee CE, Wallimann T, Gillespie PG (2007) Hair bundles are specialized for ATP delivery via creatine kinase. Neuron 53:371-386
78. Skuza G, Rogóz Z (2003) Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1, 3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats. Pol J Pharmacol 55:1149-1152
79. Stanika RI, Pivovarova NB, Brantner CA, Watts CA, Winters CA, Andrews SB (2009) Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci USA 106:9854-9859. doi:10.1073/pnas.0903546106
80. Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ (1998) Glutamate-induced neuron death requires mitochondrial calcium uptake. Nature Neurosci 1:366-373
81. Stowe DF, Camara AKS (2009) Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal 11:1373-1414
82. Streck EL, Amboni G, Scaini G, Di-Pietro PB, Rezin GT, Valvassori SS, Luz G, Kapczinski F, Quevedo J (2008) Brain creatine kinase activity in an animal model of mania. Life Sci 82:424-429. doi:10.1016/j.lfs.2007.11.026
83. Valvassori SS, Petronilho FC, Réus GZ, Steckert AV, Oliveira VB, Boeck CR, Kapczinski F, Dal-Pizzol F, Quevedo J (2008) Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 32:1064-1068. doi: 10.1016/j.pnpbp.2008.02.012
84. Volbracht C, van Beek J, Zhu C, Blomgren K, Leist M (2006) Neuroprotective properties of memantine indifferent invitro and in vivo models of excitotoxicity. Eur J Neurosci 23:2611-2622
85. Weinbach EC, Costa JL, Nelson BD, Claggett CE, Hundal T, Bradley D, Morris SJ (1986) Effects of tricyclic antidepressant drugs on energy-linked reactions in mitochondria. Biochem Pharmacol 35:1445-1451. doi:10.1016/0006- 2952(86)90108-5
86. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80:1107-1213
87. Zaja-Milatovic S, Gupta RC, Aschner M, Milatovic D (2009) Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. Toxicol Appl Pharmacol 240:124-131
88. Zarate CA Jr, Manji HK (2008) Riluzole in psychiatry: a systematic review of the literature. Expert Opin Drug Metab Toxicol 4:1223-1234. doi:10.1517/17425255.4.9.1223
89. Zarate CA Jr, Singh JB, Carson PJ, Brutshe NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864
90. Zdanys K, Tampi RR (2008) A systematic review of off-label uses of memantine for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 32:1362-1374. doi:10.1016/j.pnpbp.2008.01.008
91. Zhang X, Rojas JC, Gonzalez-Lima F (2006) Methylene blue prevents neurodegeneration caused by rotenone in the retina. Neurotox Res 9:47-57